To study whether YB1 mediates the PCa survival impacts of FGF12, we then depleted YB1 by siRNA in LNCaP cells expressing either control or FGF12 and challenged these cells with increasing doses of etoposide and camptothecin (Figure 6D). This evidence concerns the gene FGF12 and posterior cortical atrophy.